(Q64379379)

English

Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice

scientific article published on 01 December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

based on heuristic

Giorgos Kollias

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

G Schett

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Hayer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Tohidast-Akrad

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B J Schmid

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Lang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B Türk

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Kainberger

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Haralambous

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A C Newby

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Q Xu

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

G Steiner

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Smolen

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Arthritis and Rheumatism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

2888-2898

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1).

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain rea

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Insights into MMP-TIMP interactions.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1).

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2888%3A%3AAID-ART477%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/1529-0131(200112)44:12<2888::AID-ART477>3.0.CO;2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11762950%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64379379&oldid=2128323312"